Novartis’ CAR-T therapy was the first approved in U.S. — here’s how to invest in the space By: MarketWatch August 31, 2017 at 10:37 AM EDT How to get in on “the very early innings” of a growth cycle that could last a decade. Read More >> Related Stocks: Adaptimmune Ther ADR Bellicum Pharmaceuticals Inc Biolife Solutions Brooks Automation Cellectis S.A. ADR Cryoport Inc Mesa Labs Inc Novartis Ag ADR
